Published in J Virol on July 01, 2001
CD25+CD4+ T cells contribute to the control of memory CD8+ T cells. Proc Natl Acad Sci U S A (2002) 2.44
Type I interferons in infectious disease. Nat Rev Immunol (2015) 2.37
Heterologous immunity between viruses. Immunol Rev (2010) 2.20
Interferon-gamma acts directly on CD8+ T cells to increase their abundance during virus infection. J Exp Med (2005) 2.13
Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion. J Clin Invest (2004) 2.11
Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog (2007) 1.93
Private specificities of CD8 T cell responses control patterns of heterologous immunity. J Exp Med (2005) 1.85
Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: it is even bigger than we thought. J Virol (2006) 1.78
Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype. J Virol (2002) 1.67
Lung niches for the generation and maintenance of tissue-resident memory T cells. Mucosal Immunol (2013) 1.62
The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling. Nat Immunol (2013) 1.60
Plasticity in programming of effector and memory CD8 T-cell formation. Immunol Rev (2010) 1.59
TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts. J Immunol (2006) 1.57
Transient CD8-memory contraction: a potential contributor to latent cytomegalovirus reactivation. J Leukoc Biol (2012) 1.47
Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys. J Virol (2009) 1.45
Type 1 IFN mediates cross-talk between innate and adaptive immunity that abrogates transplantation tolerance. J Immunol (2007) 1.34
Chronic bystander infections and immunity to unrelated antigens. Cell Host Microbe (2012) 1.23
Primary Epstein-Barr virus infection does not erode preexisting CD8⁺ T cell memory in humans. J Exp Med (2012) 1.20
Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything. J Intern Med (2010) 1.17
Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon. J Virol (2011) 1.16
Type 1 interferons and antiviral CD8 T-cell responses. PLoS Pathog (2012) 1.15
HDAC inhibition suppresses primary immune responses, enhances secondary immune responses, and abrogates autoimmunity during tumor immunotherapy. Mol Ther (2013) 1.13
Bystander chronic infection negatively impacts development of CD8(+) T cell memory. Immunity (2014) 1.07
Analysis of apoptosis of memory T cells and dendritic cells during the early stages of viral infection or exposure to toll-like receptor agonists. J Virol (2010) 1.07
Immune memory and aging: an infinite or finite resource? Curr Opin Immunol (2010) 1.05
The Sordid Affair Between Human Herpesvirus and HIV. J Infect Dis (2015) 1.02
IFN-gamma induces the erosion of preexisting CD8 T cell memory during infection with a heterologous intracellular bacterium. J Immunol (2008) 1.00
Heterologous immunity: immunopathology, autoimmunity and protection during viral infections. Autoimmunity (2011) 0.98
Correlates of immunity to filovirus infection. Viruses (2011) 0.91
Residual inflammation and viral reservoirs: alliance against an HIV cure. Curr Opin HIV AIDS (2016) 0.90
Attrition of memory CD8 T cells. Nature (2009) 0.90
Virally activated CD8 T cells home to Mycobacterium bovis BCG-induced granulomas but enhance antimycobacterial protection only in immunodeficient mice. Infect Immun (2006) 0.88
Transcriptional profiling of the circulating immune response to lassa virus in an aerosol model of exposure. PLoS Negl Trop Dis (2013) 0.87
Lymphadenopathy in a novel mouse model of Bartonella-induced cat scratch disease results from lymphocyte immigration and proliferation and is regulated by interferon-alpha/beta. Am J Pathol (2008) 0.87
Immune responses and Lassa virus infection. Viruses (2012) 0.86
Early antiretroviral treatment prevents the development of central nervous system abnormalities in simian immunodeficiency virus-infected rhesus monkeys. AIDS (2009) 0.86
Narrowing of human influenza A virus-specific T cell receptor α and β repertoires with increasing age. J Virol (2015) 0.86
Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model. J Virol (2014) 0.86
Coxsackievirus B3 infects the bone marrow and diminishes the restorative capacity of erythroid and lymphoid progenitors. J Virol (2012) 0.86
Acute induction of cell death-related IFN stimulated genes (ISG) differentiates highly from moderately virulent CSFV strains. Vet Res (2009) 0.86
Quantitative analysis of long-term virus-specific CD8+-T-cell memory in mice challenged with unrelated pathogens. J Virol (2003) 0.86
T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee. Hepatology (2014) 0.85
Type I interferons regulate eomesodermin expression and the development of unconventional memory CD8(+) T cells. Nat Commun (2015) 0.85
Bacterial infection alters the kinetics and function of iNKT cell responses. J Leukoc Biol (2008) 0.85
Elevation and persistence of CD8 T-cells in HIV infection: the Achilles heel in the ART era. J Int AIDS Soc (2016) 0.85
CD122+CD8+ Treg suppress vaccine-induced antitumor immune responses in lymphodepleted mice. Eur J Immunol (2010) 0.84
Multiple vaccinations: friend or foe. Cancer J (2011) 0.83
NK cells improve control of friend virus infection in mice persistently infected with murine cytomegalovirus. Retrovirology (2013) 0.83
Hepatitis C virus clearance correlates with HLA-DR expression on proliferating CD8+ T cells in immune-primed chimpanzees. Hepatology (2014) 0.82
New insights into type I interferon and the immunopathogenesis of persistent viral infections. Curr Opin Immunol (2015) 0.81
The two faces of heterologous immunity: protection or immunopathology. J Leukoc Biol (2013) 0.80
IL-15-Independent Maintenance of Tissue-Resident and Boosted Effector Memory CD8 T Cells. J Immunol (2016) 0.79
Theoretical analysis of the evolution of immune memory. BMC Evol Biol (2010) 0.79
Generation and maintenance of Listeria-specific CD8+ T cell responses in perforin-deficient mice chronically infected with LCMV. Virology (2007) 0.79
Picornavirus infection leading to immunosuppression. Future Virol (2014) 0.78
Infection of CD8+CD45RO+ memory T-cells by HIV-1 and their proliferative response. Open AIDS J (2008) 0.77
Dose-dependent lymphocyte apoptosis following respiratory infection with Vaccinia virus. Virus Res (2008) 0.77
Regulatory T cells resist virus infection-induced apoptosis. J Virol (2014) 0.76
Heterologous immunity and persistent murine cytomegalovirus infection. J Virol (2016) 0.75
Regulation of tissue-dependent differences in CD8+ T cell apoptosis during viral infection. J Virol (2014) 0.75
Vaccination and heterologous immunity: educating the immune system. Trans R Soc Trop Med Hyg (2015) 0.75
Antiapoptotic Role for Lifeguard in T Cell Mediated Immune Response. PLoS One (2015) 0.75
Type I IFN Signaling Is Dispensable during Secondary Viral Infection. PLoS Pathog (2016) 0.75
The microRNA miR-31 inhibits CD8(+) T cell function in chronic viral infection. Nat Immunol (2017) 0.75
Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity (1998) 17.27
A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods (1995) 16.00
Immune response in mice that lack the interferon-gamma receptor. Science (1993) 12.15
Immunological memory and protective immunity: understanding their relation. Science (1996) 10.02
Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature (1993) 9.81
Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity (1998) 9.02
Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science (1996) 7.00
Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity (1998) 6.29
Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science (2000) 6.22
Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med (1998) 5.78
Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol (1999) 4.97
The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci U S A (1993) 4.97
Peripheral selection of the T cell repertoire. Science (1991) 4.56
Immune function in mice lacking the perforin gene. Proc Natl Acad Sci U S A (1994) 4.06
Type I interferons keep activated T cells alive. J Exp Med (1999) 3.98
Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J Exp Med (1978) 3.31
Visualization, characterization, and turnover of CD8+ memory T cells in virus-infected hosts. J Exp Med (1996) 3.26
On immunological memory. Annu Rev Immunol (1996) 3.21
Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J Exp Med (1994) 2.87
Type I interferon-mediated stimulation of T cells by CpG DNA. J Exp Med (1998) 2.58
Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity (1999) 2.55
The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen. J Exp Med (1994) 2.40
Interferon-induced antiviral actions and their regulation. Adv Virus Res (1993) 2.40
High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. J Exp Med (1993) 2.20
Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections. J Exp Med (1996) 2.14
Virus-induced polyclonal cytotoxic T lymphocyte stimulation. J Immunol (1989) 2.13
Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc Natl Acad Sci U S A (1998) 1.95
Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J Exp Med (1997) 1.93
Stability and diversity of T cell receptor repertoire usage during lymphocytic choriomeningitis virus infection of mice. J Exp Med (1998) 1.93
Fate of H2-activated T lymphocytes in syngeneic hosts. I. Fate in lymphoid tissues and intestines traced with 3H-thymidine, 125I-deoxyuridine and 51chromium. Cell Immunol (1976) 1.89
Induction of alloreactive cytotoxic T cells by acute virus infection of mice. J Immunol (1986) 1.84
Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response. J Exp Med (1997) 1.74
Blastogenesis of natural killer cells during viral infection in vivo. J Immunol (1982) 1.72
Increase in NK cell number and turnover rate during acute viral infection. J Immunol (1983) 1.65
Activation and migration of CD8 T cells in the intestinal mucosa. J Immunol (1997) 1.56
In vivo state of antiviral CTL precursors. Characterization of a cycling cell population containing CTL precursors in immune mice. J Immunol (1995) 1.52
Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr, and Bcl-2-transgenic mice. Am J Pathol (1995) 1.48
Virus-lymphocyte interactions. II. Expression of viral sequences during the course of persistent lymphocytic choriomeningitis virus infection and their localization to the L3T4 lymphocyte subset. J Immunol (1988) 1.42
Cytolytically active memory CTL present in lymphocytic choriomeningitis virus-immune mice after clearance of virus infection. J Immunol (1997) 1.33
Cytotoxic T-memory cells in virus infection and the specificity of helper T cells. Immunology (1982) 1.33
Apoptotic regulation of T cells and absence of immune deficiency in virus-infected gamma interferon receptor knockout mice. J Virol (1998) 1.32
Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc. J Exp Med (1999) 1.14
Bystander sensitization to activation-induced cell death as a mechanism of virus-induced immune suppression. J Virol (2000) 1.13
Tumor suppressor p53 as a component of the tumor necrosis factor-induced, protein kinase PKR-mediated apoptotic pathway in human promonocytic U937 cells. J Biol Chem (1998) 1.07
Abrogation of tolerance to a chronic viral infection. J Immunol (1991) 1.06
IFN induction and associated changes in splenic leukocyte distribution. J Immunol (1993) 1.04
B7 costimulates proliferation of CD4-8+ T lymphocytes but is not required for the deletion of immature CD4+8+ thymocytes. J Immunol (1992) 1.04
Fas- and activation-induced apoptosis are reduced in human T cells preactivated in the presence of TGF-beta 1. J Immunol (1996) 1.01
Transforming growth factor-beta 2 induces apoptosis of murine T cell clones without down-regulating bcl-2 mRNA expression. Eur J Immunol (1994) 0.98
Binding of viral antigens to major histocompatibility complex class I H-2Db molecules is controlled by dominant negative elements at peptide non-anchor residues. Implications for peptide selection and presentation. J Biol Chem (1996) 0.98
Recombinant interferon alpha can induce rearrangement of T-cell antigen receptor alpha-chain genes and maturation to cytotoxicity in T-lymphocyte clones in vitro. Proc Natl Acad Sci U S A (1986) 0.88
Synergistic role of type I interferons in the induction of protective cytotoxic T lymphocytes. Immunol Lett (1995) 0.82
Poly I:C or IFN-alpha/beta treatment inhibits macrophage induced T cell proliferation. J Interferon Res (1985) 0.82
Treatment of resting T lymphocytes with interferon-alpha/beta augments their proliferative response to activation signals delivered through their surface Ly-6 antigen. Cell Immunol (1986) 0.82
The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv Immunol (1980) 6.24
Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat Immunol (2001) 3.59
Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol (1983) 3.58
Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med (2001) 3.55
Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J Exp Med (1985) 3.48
Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J Exp Med (1978) 3.31
Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J Exp Med (1994) 2.87
Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J Virol (1984) 2.73
Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity (1999) 2.55
Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J Exp Med (1998) 2.53
Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J Virol (1997) 2.35
Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway. J Exp Med (1976) 2.34
CD11b (Mac-1): a marker for CD8+ cytotoxic T cell activation and memory in virus infection. J Immunol (1992) 2.32
In vitro activity of rifampin alone and in combination with nafcillin and Vancomycin against pathogenic strains of Staphylococcus aureus. Antimicrob Agents Chemother (1978) 2.21
High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. J Exp Med (1993) 2.20
Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections. J Exp Med (1996) 2.14
Virus-induced polyclonal cytotoxic T lymphocyte stimulation. J Immunol (1989) 2.13
Heterospecific cytotoxic cell activity induced during the first three days of acute lymphocytic choriomeningitis virus infection in mice. Nature (1977) 2.05
Widespread occurrence and genetic diversity of marine parasitoids belonging to Syndiniales (Alveolata). Environ Microbiol (2008) 2.01
Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol (2009) 2.00
Apoptosis in viral infections. Adv Virus Res (1995) 1.97
Some ultrastructural effects of persistent infections by the rickettsia Coxiella burnetii in mouse L cells and green monkey kidney (Vero) cells. Infect Immun (1978) 1.96
Restriction specificities, alloreactivity, and allotolerance expressed by T cells from nude mice reconstituted with H-2-compatible or -incompatible thymus grafts. J Exp Med (1980) 1.96
Stability and diversity of T cell receptor repertoire usage during lymphocytic choriomeningitis virus infection of mice. J Exp Med (1998) 1.93
Human serum lyses RNA tumour viruses. Nature (1975) 1.92
Mouse natural killer cells: induction specificity, and function. J Immunol (1978) 1.89
Programmed cell death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency. J Virol (1993) 1.85
Induction of alloreactive cytotoxic T cells by acute virus infection of mice. J Immunol (1986) 1.84
Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response. J Exp Med (1997) 1.74
Blastogenesis of natural killer cells during viral infection in vivo. J Immunol (1982) 1.72
Long-term persistent vesicular stomatitis virus and rabies virus infection of cells in vitro. J Gen Virol (1976) 1.71
Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4(+) T cells. Immunity (2001) 1.69
Regulation of virus infections by natural killer cells. A review. Nat Immun Cell Growth Regul (1986) 1.68
Increase in NK cell number and turnover rate during acute viral infection. J Immunol (1983) 1.65
Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody. J Virol (2000) 1.64
On the immunocompetence of H-2 incompatible irradiation bone marrow chimeras. J Immunol (1980) 1.62
Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells. J Immunol (2001) 1.60
In vivo state of antiviral CTL precursors. Characterization of a cycling cell population containing CTL precursors in immune mice. J Immunol (1995) 1.52
Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes. J Exp Med (1998) 1.50
Natural killer cells and interferon. Crit Rev Immunol (1984) 1.49
Interferon enhances the susceptibility of virus-infected fibroblasts to cytotoxic T cells. J Exp Med (1985) 1.49
T-cell-independent antiviral antibody responses. Curr Opin Immunol (1998) 1.49
Inhibition of immunologic injury of cultured cells infected with lymphocytic choriomeningitis virus: role of defective interfering virus in regulating viral antigenic expression. J Exp Med (1977) 1.49
Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr, and Bcl-2-transgenic mice. Am J Pathol (1995) 1.48
Accumulation and chemotaxis of natural killer/large granular lymphocytes at sites of virus replication. J Immunol (1987) 1.43
Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection. J Exp Med (1986) 1.43
Determinants of lymphocytic choriomeningitis interference. J Gen Virol (1972) 1.41
Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells. J Virol (1995) 1.40
Natural cell-mediated immunity during viral infections. Curr Top Microbiol Immunol (1981) 1.40
Induction of type I diabetes by Kilham's rat virus in diabetes-resistant BB/Wor rats. Science (1991) 1.37
Alterations of acetylcholine enzymes in neuroblastoma cells persistently infected with lymphocytic choriomeningitis virus. J Cell Physiol (1977) 1.37
Detection of a high frequency of virus-specific CD4+ T cells during acute infection with lymphocytic choriomeningitis virus. J Immunol (1998) 1.36
Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus. J Immunol (1983) 1.35
Cytolytically active memory CTL present in lymphocytic choriomeningitis virus-immune mice after clearance of virus infection. J Immunol (1997) 1.33
Generation of large granular T lymphocytes in vivo during viral infection. J Immunol (1986) 1.33
Apoptotic regulation of T cells and absence of immune deficiency in virus-infected gamma interferon receptor knockout mice. J Virol (1998) 1.32
Interferon induces natural killer cell blastogenesis in vivo. J Leukoc Biol (1984) 1.30
Natural killer cell response to lymphocytic choriomeningitis virus in beige mice. Scand J Immunol (1980) 1.30
NK cell response to viral infections in beta 2-microglobulin-deficient mice. J Immunol (1995) 1.30
Occurrence of donor Langerhans cells in mouse and rat chimeras and their replacement in skin grafts. J Invest Dermatol (1986) 1.29
T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice. J Exp Med (1996) 1.29
Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype. J Immunol (1986) 1.29
Stability of virus-specific CD4+ T cell frequencies from acute infection into long term memory. J Immunol (1998) 1.29
Effect of virus infections on target cell susceptibility to natural killer cell-mediated lysis. J Immunol (1980) 1.27
Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J Immunol (1995) 1.27
Antibody-complement interactions with purified lymphocytic choriomeningitis virus. Virology (1976) 1.27
Inactivation of lysis of oncornaviruses by human serum. Virology (1976) 1.26
Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. II. "Specificities" of the natural killer cells. J Immunol (1979) 1.24
Amantadine hydrochloride inhibition of early and late stages of lymphocytic choriomenigitis virus-cell interactions. Virology (1971) 1.23
Host cell modification of lymphocytic choriomeningitis virus and Newcastle disease virus altering viral inactivation by human complement. J Immunol (1977) 1.21
Control of infections by NK cells. Curr Top Microbiol Immunol (1998) 1.20
The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1. J Immunol (1986) 1.20
Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo. J Immunol (1985) 1.19
T-lymphocyte downregulation after acute viral infection is not dependent on CD95 (Fas) receptor-ligand interactions. J Virol (1996) 1.18
Independent regulation of lymphocytic choriomeningitis virus-specific T cell memory pools: relative stability of CD4 memory under conditions of CD8 memory T cell loss. J Immunol (2001) 1.18
High frequency of virus-specific interleukin-2-producing CD4(+) T cells and Th1 dominance during lymphocytic choriomeningitis virus infection. J Virol (2000) 1.16
Protein analysis of defective interfering lymphocytic choriomeningitis virus and persistently infected cells. Virology (1979) 1.15
Interferon-mediated protection of normal and tumor target cells against lysis by mouse natural killer cells. J Immunol (1981) 1.14
Bystander sensitization to activation-induced cell death as a mechanism of virus-induced immune suppression. J Virol (2000) 1.13
Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rγ(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells. Clin Exp Immunol (2013) 1.13
Susceptibility to cytotoxic T lymphocyte-induced apoptosis is a function of the proliferative status of the target. J Exp Med (1994) 1.12
Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes. J Immunol (1986) 1.12
Molecular characterization of Newcastle disease viruses isolated from recent outbreaks in Taiwan. J Virol Methods (2001) 1.11
Arenaviruses: cellular response to long-term in vitro infection with parana and lymphocytic choriomeningitis viruses. Infect Immun (1972) 1.10
Specificity and editing by apoptosis of virus-induced cytotoxic T lymphocytes. Curr Opin Immunol (1994) 1.10
Properties of defective lymphocytic choriomeningitis virus. J Gen Virol (1972) 1.08
Human peripheral blood CD4 T cell-engrafted non-obese diabetic-scid IL2rγ(null) H2-Ab1 (tm1Gru) Tg (human leucocyte antigen D-related 4) mice: a mouse model of human allogeneic graft-versus-host disease. Clin Exp Immunol (2011) 1.07
Expression of asialo GM1 and other antigens and glycolipids on natural killer cells and spleen leukocytes in virus-infected mice. Nat Immun Cell Growth Regul (1985) 1.07
Separation and isolation of rat natural killer (NK) cells from T cells with monoclonal antibodies. J Immunol (1984) 1.06
Interferon production during lymphocytic choriomeningitis virus infection of nude and normal mice. Nature (1977) 1.05
The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections. J Immunol (1999) 1.05
Activation and role of natural killer cells in virus infections. Med Microbiol Immunol (1982) 1.04
T-Cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles. J Virol (1998) 1.03
Alpha beta and gamma delta T-cell networks and their roles in natural resistance to viral infections. Immunol Rev (1997) 1.03